“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: O.2 A single analysis for simultaneous measurement of all 4 DOACs

€3.03

SKU: product-article-16284 Category: General

Description
Reviews (0)

Description

O.2 A single analysis for simultaneous measurement of all 4 DOACs

Reviews

There are no reviews yet.

Be the first to review “Article: O.2 A single analysis for simultaneous measurement of all 4 DOACs”

You must be logged in to post a review.

Top

Article: O.2 A single analysis for simultaneous measurement of all 4 DOACs

Description

Reviews

Related products

Article: INTRODUCTION

Article: Highlights in melanoma

Article: Highlights in respiratory oncology

Article: Highlights in digestive oncology